A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity

Robert J. Schmidt, James V. Ficorilli, Youyan Zhang, Kelli S. Bramlett, Thomas P. Beyer, Kristen Borchert, Michele S. Dowless, Keith A. Houck, Thomas P. Burris, Patrick I. Eacho, Guosheng Liang, Li Wei Guo, William K. Wilson, Laura F. Michael, Guoqing Cao

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Hypercholesterolemia is a major risk factor for coronary artery disease. Oxysterols are known to inhibit cholesterol biosynthesis and have been explored as potential antihypercholesterolemic agents. The ability of 3β-hydroxy-5α-cholest-8(14)-en-15-one (15-ketosterol) to lower non-HDL cholesterol has been demonstrated in rodent and primate models, but the mechanisms of action remain poorly understood. Here we show in a coactivator recruitment assay and cotransfection assays that the 15-ketosterol is a partial agonist for liver X receptor-α and -β (LXRα and LXRβ). The binding affinity for the LXRs was comparable to those of native oxysterols. In a macrophage cell line of human origin, the 15-ketosterol elevated ATP binding cassette transporter ABCA1 mRNA in a concentration-dependent fashion with a potency similar to those of other oxysterols. We further found that in human embryonic kidney HEK 293 cells, the 15-ketosterol suppressed sterolresponsive element binding protein processing activity and thus inhibited mRNA expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, LDL receptor, and PCSK9. Our data thus provide a molecular basis for the hypocholesterolemic activity of the 15-ketosterol and further suggest its potential antiatherosclerotic benefit as an LXR agonist.

Original languageEnglish (US)
Pages (from-to)1037-1044
Number of pages8
JournalJournal of Lipid Research
Volume47
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Sterols
Liver
Assays
Carrier Proteins
Cholesterol
Ligands
Messenger RNA
ATP-Binding Cassette Transporters
LDL Receptors
Macrophages
Biosynthesis
Oxidoreductases
HEK293 Cells
Cells
Hypercholesterolemia
Primates
Coronary Artery Disease
Rodentia
Processing
Kidney

Keywords

  • Hypercholesterolemia
  • Scintillation proximity assay
  • Statin

ASJC Scopus subject areas

  • Endocrinology

Cite this

Schmidt, R. J., Ficorilli, J. V., Zhang, Y., Bramlett, K. S., Beyer, T. P., Borchert, K., ... Cao, G. (2006). A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. Journal of Lipid Research, 47(5), 1037-1044. https://doi.org/10.1194/jlr.M500526-JLR200

A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. / Schmidt, Robert J.; Ficorilli, James V.; Zhang, Youyan; Bramlett, Kelli S.; Beyer, Thomas P.; Borchert, Kristen; Dowless, Michele S.; Houck, Keith A.; Burris, Thomas P.; Eacho, Patrick I.; Liang, Guosheng; Guo, Li Wei; Wilson, William K.; Michael, Laura F.; Cao, Guoqing.

In: Journal of Lipid Research, Vol. 47, No. 5, 05.2006, p. 1037-1044.

Research output: Contribution to journalArticle

Schmidt, RJ, Ficorilli, JV, Zhang, Y, Bramlett, KS, Beyer, TP, Borchert, K, Dowless, MS, Houck, KA, Burris, TP, Eacho, PI, Liang, G, Guo, LW, Wilson, WK, Michael, LF & Cao, G 2006, 'A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity', Journal of Lipid Research, vol. 47, no. 5, pp. 1037-1044. https://doi.org/10.1194/jlr.M500526-JLR200
Schmidt, Robert J. ; Ficorilli, James V. ; Zhang, Youyan ; Bramlett, Kelli S. ; Beyer, Thomas P. ; Borchert, Kristen ; Dowless, Michele S. ; Houck, Keith A. ; Burris, Thomas P. ; Eacho, Patrick I. ; Liang, Guosheng ; Guo, Li Wei ; Wilson, William K. ; Michael, Laura F. ; Cao, Guoqing. / A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. In: Journal of Lipid Research. 2006 ; Vol. 47, No. 5. pp. 1037-1044.
@article{78d808dbfa18401b8a5b51f4f9eef710,
title = "A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity",
abstract = "Hypercholesterolemia is a major risk factor for coronary artery disease. Oxysterols are known to inhibit cholesterol biosynthesis and have been explored as potential antihypercholesterolemic agents. The ability of 3β-hydroxy-5α-cholest-8(14)-en-15-one (15-ketosterol) to lower non-HDL cholesterol has been demonstrated in rodent and primate models, but the mechanisms of action remain poorly understood. Here we show in a coactivator recruitment assay and cotransfection assays that the 15-ketosterol is a partial agonist for liver X receptor-α and -β (LXRα and LXRβ). The binding affinity for the LXRs was comparable to those of native oxysterols. In a macrophage cell line of human origin, the 15-ketosterol elevated ATP binding cassette transporter ABCA1 mRNA in a concentration-dependent fashion with a potency similar to those of other oxysterols. We further found that in human embryonic kidney HEK 293 cells, the 15-ketosterol suppressed sterolresponsive element binding protein processing activity and thus inhibited mRNA expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, LDL receptor, and PCSK9. Our data thus provide a molecular basis for the hypocholesterolemic activity of the 15-ketosterol and further suggest its potential antiatherosclerotic benefit as an LXR agonist.",
keywords = "Hypercholesterolemia, Scintillation proximity assay, Statin",
author = "Schmidt, {Robert J.} and Ficorilli, {James V.} and Youyan Zhang and Bramlett, {Kelli S.} and Beyer, {Thomas P.} and Kristen Borchert and Dowless, {Michele S.} and Houck, {Keith A.} and Burris, {Thomas P.} and Eacho, {Patrick I.} and Guosheng Liang and Guo, {Li Wei} and Wilson, {William K.} and Michael, {Laura F.} and Guoqing Cao",
year = "2006",
month = "5",
doi = "10.1194/jlr.M500526-JLR200",
language = "English (US)",
volume = "47",
pages = "1037--1044",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity

AU - Schmidt, Robert J.

AU - Ficorilli, James V.

AU - Zhang, Youyan

AU - Bramlett, Kelli S.

AU - Beyer, Thomas P.

AU - Borchert, Kristen

AU - Dowless, Michele S.

AU - Houck, Keith A.

AU - Burris, Thomas P.

AU - Eacho, Patrick I.

AU - Liang, Guosheng

AU - Guo, Li Wei

AU - Wilson, William K.

AU - Michael, Laura F.

AU - Cao, Guoqing

PY - 2006/5

Y1 - 2006/5

N2 - Hypercholesterolemia is a major risk factor for coronary artery disease. Oxysterols are known to inhibit cholesterol biosynthesis and have been explored as potential antihypercholesterolemic agents. The ability of 3β-hydroxy-5α-cholest-8(14)-en-15-one (15-ketosterol) to lower non-HDL cholesterol has been demonstrated in rodent and primate models, but the mechanisms of action remain poorly understood. Here we show in a coactivator recruitment assay and cotransfection assays that the 15-ketosterol is a partial agonist for liver X receptor-α and -β (LXRα and LXRβ). The binding affinity for the LXRs was comparable to those of native oxysterols. In a macrophage cell line of human origin, the 15-ketosterol elevated ATP binding cassette transporter ABCA1 mRNA in a concentration-dependent fashion with a potency similar to those of other oxysterols. We further found that in human embryonic kidney HEK 293 cells, the 15-ketosterol suppressed sterolresponsive element binding protein processing activity and thus inhibited mRNA expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, LDL receptor, and PCSK9. Our data thus provide a molecular basis for the hypocholesterolemic activity of the 15-ketosterol and further suggest its potential antiatherosclerotic benefit as an LXR agonist.

AB - Hypercholesterolemia is a major risk factor for coronary artery disease. Oxysterols are known to inhibit cholesterol biosynthesis and have been explored as potential antihypercholesterolemic agents. The ability of 3β-hydroxy-5α-cholest-8(14)-en-15-one (15-ketosterol) to lower non-HDL cholesterol has been demonstrated in rodent and primate models, but the mechanisms of action remain poorly understood. Here we show in a coactivator recruitment assay and cotransfection assays that the 15-ketosterol is a partial agonist for liver X receptor-α and -β (LXRα and LXRβ). The binding affinity for the LXRs was comparable to those of native oxysterols. In a macrophage cell line of human origin, the 15-ketosterol elevated ATP binding cassette transporter ABCA1 mRNA in a concentration-dependent fashion with a potency similar to those of other oxysterols. We further found that in human embryonic kidney HEK 293 cells, the 15-ketosterol suppressed sterolresponsive element binding protein processing activity and thus inhibited mRNA expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, LDL receptor, and PCSK9. Our data thus provide a molecular basis for the hypocholesterolemic activity of the 15-ketosterol and further suggest its potential antiatherosclerotic benefit as an LXR agonist.

KW - Hypercholesterolemia

KW - Scintillation proximity assay

KW - Statin

UR - http://www.scopus.com/inward/record.url?scp=33646815299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646815299&partnerID=8YFLogxK

U2 - 10.1194/jlr.M500526-JLR200

DO - 10.1194/jlr.M500526-JLR200

M3 - Article

C2 - 16415294

AN - SCOPUS:33646815299

VL - 47

SP - 1037

EP - 1044

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 5

ER -